Kampanjeplan Exscientia Holdings Limited
Avansert tidsplan
Enkel graf
Om selskapet Exscientia Holdings Limited
Exscientia plc, фармацевтическая компания, основанная на искусственном интеллекте, занимается открытием, проектированием и разработкой лекарств. Он предлагает комплексное решение с использованием искусственного интеллекта и технологий для идентификации целей, разработки кандидатов на лекарства, трансляционных моделей и отбора пациентов. Его платформа позволяет разрабатывать молекулы-кандидаты в лекарственные препараты, а также предоставлять пациентам лекарственную терапию с помощью оценки под руководством ИИ. flere detaljerIPO date | 2021-10-01 |
---|---|
ISIN | US30223G1022 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | gbp |
Сайт | https://www.exscientia.ai |
Цена ао | 4.58 |
Prisendring per dag: | -0.4348% (4.6) |
---|---|
Prisendring per uke: | -13.58% (5.3) |
Prisendring per måned: | -6.15% (4.88) |
Prisendring over 3 måneder: | -14.71% (5.37) |
Prisendring over seks måneder: | -7.85% (4.97) |
Prisendring per år: | -2.14% (4.68) |
Prisendring over 3 år: | 0% (4.58) |
Prisendring over 5 år: | 0% (4.58) |
Prisendring over 10 år: | 0% (4.58) |
Prisendring siden begynnelsen av året: | -12.09% (5.21) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
Marshall Wace LLP | 995 | 0.82 |
Nan Fung Group Holdings Limited | 860 | 0.71 |
Softbank Group Corporation | 6 | 4.7 |
Laurion Capital Management, LP | 5 | 4.47 |
Baillie Gifford and Company | 5 | 3.78 |
Platinum Investment Management Ltd | 4 | 3.26 |
Woodline Partners LP | 2 | 1.37 |
Bill & Melinda Gates Foundation | 2 | 1.32 |
MIC Capital Management UK LLP | 2 | 1.28 |
First Trust Advisors LP | 1 | 1.18 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
Principal Healthcare Innovators ETF | 0.0252 | 618.5 | 0.8416 |
Future Tech ETF | 0.0252 | 426.34 | 0.8416 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Ben R. Taylor | CFO, Chief Strategy Officer & Executive Director | 531.62k | 1977 (48 år) |
Ms. Sara Sherman | Vice President of Investor Relations | N/A | |
Mr. Dan Ireland | Executive VP of Legal & Company Secretary | N/A | |
Dr. David Hallett Ph.D. | Chief Scientific Officer, Interim CEO, Principal Executive Officer & Executive Director | N/A | 1969 (56 år) |
Ms. Caroline Rowland | Chief People Officer | N/A | |
Mr. Richard Law | Chief Business Officer | N/A | |
Mr. Parker Moss | Executive Vice President of Corporate Development | N/A | |
Dr. John P. Overington Ph.D. | Chief Technology Officer | N/A | |
Mr. Nikolaus Krall | Executive Vice President of Precision Medicine | ||
Dr. Marie-Louise Helena Fjallskog M.D., Ph.D. | Interim Chief Medical Officer & Clinical Development Lead | 1964 (61 år) |
Adresse: United Kingdom, Oxford, The SchrOedinger Building - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.exscientia.ai
Nettsted: https://www.exscientia.ai